A

Alopexx, Inc.

Symbol pendingFiled

Alopexx, Inc. · Exchange pending · Research source · S-1/A · 2026-09-17 · Latest filing · S-1/A · 2026-11-06 SEC ↗

Report source
Research source · S-1/A · 2026-09-17
SummaryBASIC RESEARCHReport source · S-1/A

IPO research

As of the linked September 17, 2026 S-1/A, Alopexx has not completed its proposed IPO and is developing clinical-stage PNAG-targeted immune therapeutics.

Full source-backed summary

As of the September 17, 2026 S-1/A, Alopexx proposes a 3,000,000-share firm-commitment IPO at $10.00–$12.00 per share, but the registration statement remains preliminary and effectiveness, pricing, listing, trading and closing are unconfirmed.

As of the linked September 17, 2026 S-1/A, Alopexx has not completed its proposed IPO and is developing clinical-stage PNAG-targeted immune therapeutics.

Ownership and votingAwaiting verified holder data— economic · — voting
Next disclosed checkpointNext disclosed milestone is SEC effectiveness and offering pricing; neither is dated or confirmed. NYSE American listing remains conditional and unconfirmed.S-1/A · 2026-09-17
Business and development direction

Alopexx, Inc.

Current business
Future development
DECISION DRIVERS

Key risks

Risk 1

Neither AV0328 nor F598 is approved for commercial sale, and the company has not demonstrated completion of pivotal development or commercialization.

Risk 2

Regulators may require field efficacy trials rather than relying on surrogate OPK endpoints for AV0328.

Risk 3

The company relies on Bharat as a single vaccine CMO and may face costly, time-consuming transition if supply is interrupted.

Next checkNext disclosed milestone is SEC effectiveness and offering pricing; neither is dated or confirmed. NYSE American listing remains conditional and unconfirmed.
Latest filing2026-11-06
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Offering qualitySome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
BOOKRUNNERS / LEAD UNDERWRITERSUnderwriters named in the prospectus
PRELIMINARY
#InstitutionUnderwriting allocationRatioShares
1ThinkEquity LLC
Source and calculation

Names are explicitly identified in source underwriting tables or role clauses. Quantities require the named firm's own table row; missing allocations are not inferred.

Source · S-1/A ↗

IPO CAPITAL QUALITY

Shares offered Shares3,000,000
Basis and evidence

S-1/A · 2026-09-17

As of the linked September 17, 2026 S-1/A, Alopexx has not completed its proposed IPO and is developing clinical-stage PNAG-targeted immune therapeutics.

Offering structure

Offering terms
MeasureReported valueUnit
Shares offered3,000,000Shares
Source and calculation

Prospectus offering table; stated base scenario and source conditions Figures retain their stated source scenario and conditions.

Shares offered

Prospectus offering table; stated base scenario and source conditions

SEC table 8 row 2; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Use of proceedsSource-linked structured inputs are not yet available. Open filing ↗

Dilution and valuation

IPO price—
Basic post-offer—
Equity value—

Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.

Dilution and valuation
CalculationSharesValueReference
Post-offer shares — as disclosed8,350,506—
Reported sourcePost-offersharesBasis and evidence 1 ↗
Post-offer shares — full option8,800,506—
Reported sourcePost-offer · Full optionsharesBasis and evidence 2 ↗
Capitalization shares — pro forma5,350,506—
Reported sourceCommon Stock; pro formasharesBasis and evidence 3 ↗
Capitalization shares — pro forma as adjusted8,350,506—
Reported sourceCommon Stock; pro forma as adjustedsharesBasis and evidence 4 ↗
Shares offered3,000,000—
Reported sourcePost-offer · BasesharesBasis and evidence 5 ↗
Basis and evidence ↗
Basis and evidence 1

Prospectus share summary; Common stock to be outstanding immediately after this Offering(1); 8,350,506 shares (8,800,506 shares if the underwriters exercise their over-allotment option in full).; selected security: shares; selected scenario: as disclosed; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 8 row 4 columns 3; share summary; label column 1; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗

Basis and evidence 2

Prospectus share summary; Common stock to be outstanding immediately after this Offering(1); 8,350,506 shares (8,800,506 shares if the underwriters exercise their over-allotment option in full).; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 8 row 4 columns 3; share summary; label column 1; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗

Basis and evidence 3

Capitalization share count; source stage: pro forma; Common Stock, $.0001 par value – 100,000,000 shares authorized, 5,155,081 shares issued and outstanding, 5,350,506 shares issued and outstanding pro forma, 8,350,506 shares issued and outstanding pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator

Figures retain their stated source scenario and conditions.

SEC table 11 row 7 columns 1; share summary; label column 1; source 1144647:1236381; SHA256 e728f367cda21130589bc3a6019fce1db46cee7cdf1055d8848faf63eb4711a9 ↗

Basis and evidence 4

Capitalization share count; source stage: pro forma as adjusted; Common Stock, $.0001 par value – 100,000,000 shares authorized, 5,155,081 shares issued and outstanding, 5,350,506 shares issued and outstanding pro forma, 8,350,506 shares issued and outstanding pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator

Figures retain their stated source scenario and conditions.

SEC table 11 row 7 columns 1; share summary; label column 1; source 1144647:1236381; SHA256 e728f367cda21130589bc3a6019fce1db46cee7cdf1055d8848faf63eb4711a9 ↗

Basis and evidence 5

Prospectus offering table; stated base scenario and source conditions

Prospectus offering table; stated base scenario and source conditions Figures retain their stated source scenario and conditions.

SEC table 8 row 2; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗

Share-count comparison

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Source ↗
SCENARIO · NOT A FORECAST

IPO valuation scenario simulator

Source inputs required

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source ↗
Implied equity value—Price × post-offer shares
Post-offer shares—Share count, not tradable float
Existing-holder ownership reduction—Assumes new shares only; secondary sales do not increase shares.
Source and calculation ↗
Security and offer price

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Base post-offer shares

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Equity value

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Share-count change

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Alternative scenarios

Each reported full-option, actual, diluted or class-specific case remains independent; no class sum or cross-date substitution is inferred.

Sensitivity

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source and calculation

The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.

Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Ownership across stagesSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
As of
2026-09-17
!Daniel Vlock is expected to beneficially own 56.1% after the offering, including specified options and note-conversion shares, and the company expects controlled-company status. The management/director/5% holder group is shown at 66.1% beneficial ownership after the offering, while a risk disclosure separately cites approximately 72.9% voting ownership; the supplied evidence does not reconcile this distinction.View source ↗
Relationship filters
Show
ownership / voting rights
Select for details · Alopexx, Inc.
Founder / personFund / entityPublic floatShare classEvery relationship is dated and linked to its supporting SEC filing. Percentages marked * are filing-based estimates.

Holdings and voting rights

Holder groups may overlap; these rows are not an additive ownership partition.

Holdings and voting rights
Holder / measureSharesOwnershipVoting rightsReference
Daniel VlockOwnership as disclosed—56.1%Beneficial—
Source statement; as stated; source predicate: will hold; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of our outstanding common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60; not an additive ownership partitionDisclosedEvidence
our executive officers, directors and 5% stockholdersOwnership as disclosed—approximately 97.84%Beneficial—
Source statement; approximately ; source predicate: beneficially owned; primary source clause; full source conditions retained; source scope: of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately; not an additive ownership partitionDisclosedEvidence
our executive officers, directors and 5% stockholdersOwnership as disclosed—approximately 72.9%Beneficial—
Source statement; approximately ; source predicate: will continue to beneficially own; primary source clause; full source conditions retained; source scope: of our outstanding voting stock; not an additive ownership partitionDisclosedEvidence
Daniel VlockVoting power——approximately 56.1%Voting power
Source statement; approximately ; source predicate: will beneficially own; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of the voting power of our common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable wi; not an additive ownership partitionDisclosedEvidence
Daniel VlockBeneficial shares4,546,958——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Daniel VlockBeneficial shares4,684,334——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Peter WerthBeneficial shares535,623——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Peter WerthBeneficial shares568,967——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Dr. Gerald PierBeneficial shares627,850——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Dr. Gerald PierBeneficial shares627,850——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Gail H. CassellBeneficial shares11,600——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Gail H. CassellBeneficial shares11,600——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Richard CohenBeneficial shares11,600——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Richard CohenBeneficial shares11,600——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Ann MacDougallBeneficial shares11,600——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Ann MacDougallBeneficial shares11,600——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Daniel VlockBeneficial ownership—87.2%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Daniel VlockBeneficial ownership—56.1%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Peter WerthBeneficial ownership—10.4%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Peter WerthBeneficial ownership—6.8%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Dr. Gerald PierBeneficial ownership—11.1%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Dr. Gerald PierBeneficial ownership—7.5%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Gail H. CassellBeneficial ownership—0.2%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Gail H. CassellBeneficial ownership—0.1%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Richard CohenBeneficial ownership—0.2%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Richard CohenBeneficial ownership—0.1%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Ann MacDougallBeneficial ownership—0.2%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Ann MacDougallBeneficial ownership—0.1%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Christine de los ReyesBeneficial shares191,400——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Christine de los ReyesBeneficial shares191,400——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
William W. ChinBeneficial shares281,213——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
William W. ChinBeneficial shares281,213——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Thomas T. ThomasBeneficial shares328,425——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
Thomas T. ThomasBeneficial shares328,425——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial shares5,382,796——
Shares Beneficially OwnedBefore Offering; Number of SharesDisclosedEvidence
All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial shares5,520,172——
Shares Beneficially OwnedAfter Offering; Number of SharesDisclosedEvidence
Christine de los ReyesBeneficial ownership—3.6%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Christine de los ReyesBeneficial ownership—2.3%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
William W. ChinBeneficial ownership—5.2%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
William W. ChinBeneficial ownership—3.4%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Thomas T. ThomasBeneficial ownership—6%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
Thomas T. ThomasBeneficial ownership—3.9%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial ownership—89%Beneficial—
Shares Beneficially OwnedBefore Offering; PercentageDisclosedEvidence
All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial ownership—66.1%Beneficial—
Shares Beneficially OwnedAfter Offering; PercentageDisclosedEvidence
Source and calculation ↗
Daniel Vlock · Daniel Vlock — Ownership as disclosed · 56.1%

Source statement; as stated; source predicate: will hold; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of our outstanding common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60; not an additive ownership partition

Upon completion of this offering, Daniel Vlock, our President and Chief Executive Officer, will hold a majority of the voting power of our capital stock through his beneficial ownership of 56.1% of our outstanding common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option. As a result, we will be a “controlled company” under the listing requirements of the NYSE American, or the NYSE American Marketplace Rules. We do not intend to rely on any exemptions from the corporate governance requirements of the NYSE American Marketplace Rules. See the section titled “Management — Controlled Company Status.”

0001213900-26-101026 · SEC ownership paragraph; source 51443:52711; SHA256 284e1c104eee86b7212ec4c4e02ee6374a6b88ec762c472f55f8d64a1e394192 ↗

our executive officers, directors and 5% stockholders · our executive officers, directors and 5% stockholders — Ownership as disclosed · approximately 97.84%

Source statement; approximately ; source predicate: beneficially owned; primary source clause; full source conditions retained; source scope: of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately; not an additive ownership partition

Prior to this offering, our executive officers, directors and 5% stockholders beneficially owned approximately 97.84% of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately 72.9% of our outstanding voting stock. Accordingly, even after this offering, these stockholders will have the ability to influence us through this ownership position and significantly affect the outcome of all matters requiring stockholder approval. For example, these stockholders may be able to significantly affect the outcome of elections of directors, amendments of our organizational documents or approval of any merger, sale of assets or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. In addition, these stockholders acquired their shares of common stock for substantially less than the price of the shares of common stock being acquired in this offering, and these stockholders may have interests, with respect to their common stock, that are different from those of investors in this offering and the concentration of voting power among these stockholders may have an adverse effect on the price of our common stock.

0001213900-26-101026 · SEC ownership paragraph; source 1034743:1036442; SHA256 9806d2fe2f6c1ef5e2bd5b6e1b18f0efb9cbe6b3d6b0a23bc60a2023e3d4ec22 ↗

our executive officers, directors and 5% stockholders · our executive officers, directors and 5% stockholders — Ownership as disclosed · approximately 72.9%

Source statement; approximately ; source predicate: will continue to beneficially own; primary source clause; full source conditions retained; source scope: of our outstanding voting stock; not an additive ownership partition

Prior to this offering, our executive officers, directors and 5% stockholders beneficially owned approximately 97.84% of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately 72.9% of our outstanding voting stock. Accordingly, even after this offering, these stockholders will have the ability to influence us through this ownership position and significantly affect the outcome of all matters requiring stockholder approval. For example, these stockholders may be able to significantly affect the outcome of elections of directors, amendments of our organizational documents or approval of any merger, sale of assets or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. In addition, these stockholders acquired their shares of common stock for substantially less than the price of the shares of common stock being acquired in this offering, and these stockholders may have interests, with respect to their common stock, that are different from those of investors in this offering and the concentration of voting power among these stockholders may have an adverse effect on the price of our common stock.

0001213900-26-101026 · SEC ownership paragraph; source 1034743:1036442; SHA256 9806d2fe2f6c1ef5e2bd5b6e1b18f0efb9cbe6b3d6b0a23bc60a2023e3d4ec22 ↗

Daniel Vlock · Daniel Vlock — Voting power · approximately 56.1%

Source statement; approximately ; source predicate: will beneficially own; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of the voting power of our common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable wi; not an additive ownership partition

Following this offering, Daniel Vlock, our President and Chief Executive Officer, will beneficially own approximately 56.1% of the voting power of our common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option. As a result, we will be a “controlled company” within the meaning of the NYSE American corporate governance standards. Under these corporate governance standards, a company of which more than 50% of the voting power in the election of directors is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements. For example, controlled companies are not required to have:

0001213900-26-101026 · SEC ownership paragraph; source 1098214:1099525; SHA256 762f11c3cb6262f9f8da5407124e748f852cf5f317463339bcee78902cd69669 ↗

Daniel Vlock · Daniel Vlock — Beneficial shares · 4,546,958

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Daniel Vlock(2)

0001213900-26-101026 · SEC table 29 row 4 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3; corroborating ownership row 8 columns 3 ↗

Daniel Vlock · Daniel Vlock — Beneficial shares · 4,684,334

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Daniel Vlock(2)

0001213900-26-101026 · SEC table 29 row 4 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7; corroborating ownership row 8 columns 8 ↗

Peter Werth · Peter Werth — Beneficial shares · 535,623

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Peter Werth

0001213900-26-101026 · SEC table 29 row 5 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

Peter Werth · Peter Werth — Beneficial shares · 568,967

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Peter Werth

0001213900-26-101026 · SEC table 29 row 5 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

Dr. Gerald Pier · Dr. Gerald Pier — Beneficial shares · 627,850

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Dr. Gerald Pier

0001213900-26-101026 · SEC table 29 row 6 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

Dr. Gerald Pier · Dr. Gerald Pier — Beneficial shares · 627,850

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Dr. Gerald Pier

0001213900-26-101026 · SEC table 29 row 6 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

Gail H. Cassell · Gail H. Cassell — Beneficial shares · 11,600

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Gail H. Cassell

0001213900-26-101026 · SEC table 29 row 9 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

Gail H. Cassell · Gail H. Cassell — Beneficial shares · 11,600

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Gail H. Cassell

0001213900-26-101026 · SEC table 29 row 9 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

Richard Cohen · Richard Cohen — Beneficial shares · 11,600

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Richard Cohen

0001213900-26-101026 · SEC table 29 row 10 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

Richard Cohen · Richard Cohen — Beneficial shares · 11,600

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Richard Cohen

0001213900-26-101026 · SEC table 29 row 10 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

Ann MacDougall · Ann MacDougall — Beneficial shares · 11,600

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Ann MacDougall

0001213900-26-101026 · SEC table 29 row 11 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

Ann MacDougall · Ann MacDougall — Beneficial shares · 11,600

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Ann MacDougall

0001213900-26-101026 · SEC table 29 row 11 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

Daniel Vlock · Daniel Vlock — Beneficial ownership · 87.2%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Daniel Vlock(2)

0001213900-26-101026 · SEC table 29 row 4 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5; corroborating ownership row 8 columns 5,6 ↗

Daniel Vlock · Daniel Vlock — Beneficial ownership · 56.1%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Daniel Vlock(2)

0001213900-26-101026 · SEC table 29 row 4 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9; corroborating ownership row 8 columns 11,12 ↗

Peter Werth · Peter Werth — Beneficial ownership · 10.4%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Peter Werth

0001213900-26-101026 · SEC table 29 row 5 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

Peter Werth · Peter Werth — Beneficial ownership · 6.8%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Peter Werth

0001213900-26-101026 · SEC table 29 row 5 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

Dr. Gerald Pier · Dr. Gerald Pier — Beneficial ownership · 11.1%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Dr. Gerald Pier

0001213900-26-101026 · SEC table 29 row 6 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

Dr. Gerald Pier · Dr. Gerald Pier — Beneficial ownership · 7.5%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Dr. Gerald Pier

0001213900-26-101026 · SEC table 29 row 6 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

Gail H. Cassell · Gail H. Cassell — Beneficial ownership · 0.2%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Gail H. Cassell

0001213900-26-101026 · SEC table 29 row 9 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

Gail H. Cassell · Gail H. Cassell — Beneficial ownership · 0.1%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Gail H. Cassell

0001213900-26-101026 · SEC table 29 row 9 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

Richard Cohen · Richard Cohen — Beneficial ownership · 0.2%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Richard Cohen

0001213900-26-101026 · SEC table 29 row 10 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

Richard Cohen · Richard Cohen — Beneficial ownership · 0.1%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Richard Cohen

0001213900-26-101026 · SEC table 29 row 10 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

Ann MacDougall · Ann MacDougall — Beneficial ownership · 0.2%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Ann MacDougall

0001213900-26-101026 · SEC table 29 row 11 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

Ann MacDougall · Ann MacDougall — Beneficial ownership · 0.1%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Ann MacDougall

0001213900-26-101026 · SEC table 29 row 11 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

Christine de los Reyes · Christine de los Reyes — Beneficial shares · 191,400

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Christine de los Reyes

0001213900-26-101026 · SEC table 29 row 12 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

Christine de los Reyes · Christine de los Reyes — Beneficial shares · 191,400

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Christine de los Reyes

0001213900-26-101026 · SEC table 29 row 12 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

William W. Chin · William W. Chin — Beneficial shares · 281,213

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: William W. Chin

0001213900-26-101026 · SEC table 29 row 13 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

William W. Chin · William W. Chin — Beneficial shares · 281,213

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: William W. Chin

0001213900-26-101026 · SEC table 29 row 13 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

Thomas T. Thomas · Thomas T. Thomas — Beneficial shares · 328,425

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Thomas T. Thomas

0001213900-26-101026 · SEC table 29 row 14 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

Thomas T. Thomas · Thomas T. Thomas — Beneficial shares · 328,425

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Thomas T. Thomas

0001213900-26-101026 · SEC table 29 row 14 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

All Directors, Executive Officers and Director Nominees as a group (7 persons) · All Directors, Executive Officers and Director Nominees as a group (7 persons) — Beneficial shares · 5,382,796

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)

0001213900-26-101026 · SEC table 29 row 15 columns 3; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:3 ↗

All Directors, Executive Officers and Director Nominees as a group (7 persons) · All Directors, Executive Officers and Director Nominees as a group (7 persons) — Beneficial shares · 5,520,172

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)

0001213900-26-101026 · SEC table 29 row 15 columns 8; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:7 ↗

Christine de los Reyes · Christine de los Reyes — Beneficial ownership · 3.6%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Christine de los Reyes

0001213900-26-101026 · SEC table 29 row 12 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

Christine de los Reyes · Christine de los Reyes — Beneficial ownership · 2.3%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Christine de los Reyes

0001213900-26-101026 · SEC table 29 row 12 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

William W. Chin · William W. Chin — Beneficial ownership · 5.2%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: William W. Chin

0001213900-26-101026 · SEC table 29 row 13 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

William W. Chin · William W. Chin — Beneficial ownership · 3.4%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: William W. Chin

0001213900-26-101026 · SEC table 29 row 13 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

Thomas T. Thomas · Thomas T. Thomas — Beneficial ownership · 6%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Thomas T. Thomas

0001213900-26-101026 · SEC table 29 row 14 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

Thomas T. Thomas · Thomas T. Thomas — Beneficial ownership · 3.9%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Thomas T. Thomas

0001213900-26-101026 · SEC table 29 row 14 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

All Directors, Executive Officers and Director Nominees as a group (7 persons) · All Directors, Executive Officers and Director Nominees as a group (7 persons) — Beneficial ownership · 89%

Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)

0001213900-26-101026 · SEC table 29 row 15 columns 5,6; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:3,2:5 ↗

All Directors, Executive Officers and Director Nominees as a group (7 persons) · All Directors, Executive Officers and Director Nominees as a group (7 persons) — Beneficial ownership · 66.1%

Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition

Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)

0001213900-26-101026 · SEC table 29 row 15 columns 11,12; source 2850480:2958378; SHA256 41535563c9da136868f2088e43d42be96ac36777e9591d1d5b44b5439cb6bff8; ownership header cells 1:5,2:9 ↗

Economic ownership

A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.

Share supply

Source lock-up conditions

Literal month restriction; after date of this prospectus; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
Our executive officers and directorsAfter date of this prospectus · Source conditions apply12 months
Our executive officers and directorsAfter date of this prospectus · Source conditions apply12 months
our stockholdersAfter date of this prospectus · Source conditions apply6 months
our stockholdersAfter date of this prospectus · Source conditions apply6 months
Source and calculation
Our executive officers and directors

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC lock-up paragraph; source 214766:215682; SHA256 66834fcf3d774b620abe544f6b3f3ff7140ab2dfc3ccbdc777b210153f0c5981 ↗
Our executive officers and directors

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC table 8 row 7; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗
our stockholders

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC lock-up paragraph; source 214766:215682; SHA256 66834fcf3d774b620abe544f6b3f3ff7140ab2dfc3ccbdc777b210153f0c5981 ↗
our stockholders

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC table 8 row 7; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗

Source lock-up conditions

Source lock-up conditions
MeasureReported value
We, along with our directors, executive officers and all of our other stockholders and option holders,After date of this prospectus · Source conditions apply365 days
the warrantsAfter effective date of the registration statement · Source conditions apply180 days
Source and calculation
We, along with our directors, executive officers and all of our other stockholders and option holders,

We, along with our directors, executive officers and all of our other stockholders and option holders, have agreed with the underwriters that for a period of 365 days with respect to us, our directors and executive officers and 180 days with respect to all of our other stockholders and option holders, after the date of this prospectus, subject to specified exceptions as detailed further in the section entitled “Underwriting,” we or they will not, except with the prior written consent of ThinkEquity offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to sale of, or otherwise dispose of or transfer any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock, request or demand that we file a registration statement related to our common stock or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common stock. All of our stockholders are subject to a market stand-off agreement with us which imposes similar restrictions.

SEC lock-up paragraph; source 3001250:3002859; SHA256 7be8ad8253006ced8e7bf463ae7934930a9af07b5daffe51a27c5d7820886c96 ↗
the warrants

The Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for registration rights upon request, in certain cases. The one-time demand registration right provided will not be greater than five years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(C). The unlimited piggyback registration right provided will not be greater than seven years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.

SEC lock-up paragraph; source 3085884:3088019; SHA256 fe72cc4c6049f427c0bcb8b546d3f8a17e44c85d13665285312a8ee437e54eb2 ↗

Conditional lock-up timeline

Conditional lock-up timeline

Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.

date of this prospectus

  1. our stockholdersOur executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
  2. Our executive officers and directorsOur executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
Holder / event
Holder / eventTerm / dateConditions
Our executive officers and directors12 monthsOur executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
our stockholders6 monthsOur executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

date of this prospectus

  1. We, along with our directors, executive officers and all of our other stockholders and option holders,We, along with our directors, executive officers and all of our other stockholders and option holders, have agreed with the underwriters that for a period of 365 days with respect to us, our directors and executive officers and 180 days with respect to all of our other stockholders and option holders, after the date of this prospectus, subject to specified exceptions as detailed further in the section entitled “Underwriting,” we or they will not, except with the prior written consent of ThinkEquity offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to sale of, or otherwise dispose of or transfer any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock, request or demand that we file a registration statement related to our common stock or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common stock. All of our stockholders are subject to a market stand-off agreement with us which imposes similar restrictions.
Holder / event
Holder / eventTerm / dateConditions
We, along with our directors, executive officers and all of our other stockholders and option holders,365 daysWe, along with our directors, executive officers and all of our other stockholders and option holders, have agreed with the underwriters that for a period of 365 days with respect to us, our directors and executive officers and 180 days with respect to all of our other stockholders and option holders, after the date of this prospectus, subject to specified exceptions as detailed further in the section entitled “Underwriting,” we or they will not, except with the prior written consent of ThinkEquity offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to sale of, or otherwise dispose of or transfer any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock, request or demand that we file a registration statement related to our common stock or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common stock. All of our stockholders are subject to a market stand-off agreement with us which imposes similar restrictions.

effective date of the registration statement

  1. the warrantsThe Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for registration rights upon request, in certain cases. The one-time demand registration right provided will not be greater than five years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(C). The unlimited piggyback registration right provided will not be greater than seven years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.
Holder / event
Holder / eventTerm / dateConditions
the warrants180 daysThe Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for registration rights upon request, in certain cases. The one-time demand registration right provided will not be greater than five years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(C). The unlimited piggyback registration right provided will not be greater than seven years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.
Basis and evidence
Our executive officers and directors

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC lock-up paragraph; source 214766:215682; SHA256 66834fcf3d774b620abe544f6b3f3ff7140ab2dfc3ccbdc777b210153f0c5981 ↗
our stockholders

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC lock-up paragraph; source 214766:215682; SHA256 66834fcf3d774b620abe544f6b3f3ff7140ab2dfc3ccbdc777b210153f0c5981 ↗
We, along with our directors, executive officers and all of our other stockholders and option holders,

We, along with our directors, executive officers and all of our other stockholders and option holders, have agreed with the underwriters that for a period of 365 days with respect to us, our directors and executive officers and 180 days with respect to all of our other stockholders and option holders, after the date of this prospectus, subject to specified exceptions as detailed further in the section entitled “Underwriting,” we or they will not, except with the prior written consent of ThinkEquity offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to sale of, or otherwise dispose of or transfer any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock, request or demand that we file a registration statement related to our common stock or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common stock. All of our stockholders are subject to a market stand-off agreement with us which imposes similar restrictions.

SEC lock-up paragraph; source 3001250:3002859; SHA256 7be8ad8253006ced8e7bf463ae7934930a9af07b5daffe51a27c5d7820886c96 ↗
the warrants

The Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for registration rights upon request, in certain cases. The one-time demand registration right provided will not be greater than five years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(C). The unlimited piggyback registration right provided will not be greater than seven years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.

SEC lock-up paragraph; source 3085884:3088019; SHA256 fe72cc4c6049f427c0bcb8b546d3f8a17e44c85d13665285312a8ee437e54eb2 ↗

Financial quality

Bars compare absolute amounts within each measure. Each measure has its own scale.

Net income / (loss)

$ · Annual values as reported
FY2024($3,060,624)
FY2025($2,608,394)

Operating cash flow

$ · Annual values as reported
FY2024($481,234)
FY2025($1,140,128)
Financial quality
CalculationFY2024FY2025
Net income / (loss)($3,060,624)($2,608,394)
Operating cash flow($481,234)($1,140,128)
Financial quality
CalculationReported value
Current assets2026-06-30 · Unaudited$981,003
Current assets2025-12-31$911,886
Total assets2026-06-30 · Unaudited$981,003
Total assets2025-12-31$911,886
Current liabilities2026-06-30 · Unaudited$5,036,726
Current liabilities2025-12-31$6,203,025
Total liabilities2026-06-30 · Unaudited$7,403,393
Total liabilities2025-12-31$7,003,025
Total equity / (deficit)2026-06-30 · Unaudited($6,422,390)
Total equity / (deficit)2025-12-31($6,091,139)
General and administrative expenses3M ended 2026-06-30 · Unaudited$256,981
General and administrative expenses3M ended 2025-06-30 · Unaudited$618,514
General and administrative expenses6M ended 2026-06-30 · Unaudited$604,164
General and administrative expenses6M ended 2025-06-30 · Unaudited$1,277,540
Net income / (loss)3M ended 2026-06-30 · Unaudited($541,829)
Net income / (loss)3M ended 2025-06-30 · Unaudited($746,042)
Net income / (loss)6M ended 2026-06-30 · Unaudited($1,010,625)
Net income / (loss)6M ended 2025-06-30 · Unaudited($1,529,267)
Operating cash flow6M ended 2026-06-30 · Unaudited($530,883)
Operating cash flow6M ended 2025-06-30 · Unaudited($626,962)
Current assets2024-12-31$1,152,014
Total assets2024-12-31$1,152,014
Current liabilities2024-12-31$6,078,307
Total liabilities2024-12-31$6,278,307
General and administrative expensesFY2025$2,118,730
General and administrative expensesFY2024$2,590,815
Basis and evidence
Total Current Assets
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total Current Assets
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL ASSETS
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
TOTAL ASSETS
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total Current Liabilities
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total Current Liabilities
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL LIABILITIES
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
TOTAL LIABILITIES
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total stockholders’ deficit
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total stockholders’ deficit
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
General and administrative
3M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 3 months ended 2026-06-30
General and administrative
3M ended 2025-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 3 months ended 2025-06-30
General and administrative
6M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
General and administrative
6M ended 2025-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2025-06-30
NET LOSS
3M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 3 months ended 2026-06-30
NET LOSS
3M ended 2025-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 3 months ended 2025-06-30
NET LOSS
6M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
NET LOSS
6M ended 2025-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2025-06-30
NET CASH USED IN OPERATING ACTIVITIES
6M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
NET CASH USED IN OPERATING ACTIVITIES
6M ended 2025-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2025-06-30
Total Current Assets
December 31, 2024; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
TOTAL ASSETS
December 31, 2024; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total Current Liabilities
December 31, 2024; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
TOTAL LIABILITIES
December 31, 2024; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
General and administrative
FY2025; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
General and administrative
FY2024; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
NET LOSS
FY2025; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
NET LOSS
FY2024; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
NET CASH USED IN OPERATING ACTIVITIES
FY2025; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
NET CASH USED IN OPERATING ACTIVITIES
FY2024; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
Financial quality and runway
Financial review

Financial quality and runway

Latest supplied financial information covers six months ended June 30, 2026 and balance-sheet data as of June 30, 2026. The company reports no product-sale revenue in the supplied evidence, a $1.01 million net loss for the latest six months, $97,586 cash, $1.45 million notes payable, and a going-concern warning.

Total Current Assets$981,003
Total Current Assets$911,886
TOTAL ASSETS$981,003
EvidenceFinancial review 1

Net loss was $1,010,625 for the six months ended June 30, 2026, compared with $1,529,267 for the comparable 2025 period.

EvidenceFinancial review 2

2025 and 2024 net losses were $2,608,394 and $3,060,624, respectively; accumulated deficit was $17,723,578 at June 30, 2026.

EvidenceFinancial review 3

The independent auditor’s report for 2025 included an explanatory paragraph regarding substantial doubt about going concern.

LATEST COMPARISON

MATERIAL CHANGES

The latest material signals and their investor impact are shown below.

Open S-1/A ↗
CHANGE 01Updated financial base date and capitalization

Why it mattersThe current filing uses June 30/August 31, 2026 data, increases assumed post-offering shares from 8,349,352 to 8,350,506, and changes pro forma cash from $490,278 to $97,586 before offering proceeds.

Evidence · The Offering; Capitalization
IPO177 explains the investment effect; the SEC source remains the authoritative record. Page-level locators are shown only when extracted and verified.

Loading filing history…

Risk 1

Neither AV0328 nor F598 is approved for commercial sale, and the company has not demonstrated completion of pivotal development or commercialization.

Risk 2

Regulators may require field efficacy trials rather than relying on surrogate OPK endpoints for AV0328.

Risk 3

The company relies on Bharat as a single vaccine CMO and may face costly, time-consuming transition if supply is interrupted.

Risk 4

The company reports substantial doubt about going concern and may need additional capital even after the offering.

DocumentS-1/A0001213900-26-101026
Filed2026-09-17SEC EDGAR
Research updated2026-09-18Analysed
Source-bound table inputs77SEC EDGAR
Open filing ↗